Market Overview

Analysts Come Out Bullish On Radius Health, Shares Rally

Related RDUS
Benzinga's Top Initiations
Canaccord Genuity Initiates Radius Health At Buy

Early Wednesday morning, four analyst firms issued notes initiating bullish coverage on Radius Health (NASDAQ: RDUS).

Shares of Radius Health have shot up nearly six percent on the news. The firms respective ratings and price targets are listed below.

  • Canaccord Genuity - Buy, $21
  • Cowen & Company - Outperform, N/A
  • Cantor Fitzgerald - Buy, $20
  • Jefferies - Buy, $17

The average of these price targets is $19.33, which represents 53 percent upside to last check price of $12.62.

Posted-In: Canaccord Genuity Cantor FitzgeraldAnalyst Color Price Target Initiation Hot Analyst Ratings Movers

 

Most Popular

Related Articles (RDUS)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters